¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Path Buffered Neutral Formalin Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin
    Æ÷¸£¸»¸°
  • phosphate-buffered saline
    Àλ꿰¿ÏÃæ½Ä¿°¼ö
  • association path
    ¿¬ÇÕµµ
  • condyle path
    °üÀýÀ¶±â·Î
  • incisor path
    ¾Õ´Ï±æ, ÀýÄ¡·Î
  • neutral fat
    Áß¼ºÁö¹æ
  • neutral occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • neutral reaction
    Áß¼º¹ÝÀÀ, ÁßÈ­¹ÝÀÀ
  • neutral salt
    Áß¼º¿°
  • neutral stain
    Áß¼º¿°»ö
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î
  • path
    °æ·Î, Åë·Î
  • path analysis
    °æ·ÎºÐ¼®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path analysis
    °æ·ÎºÐ¼®
  • path
    °æ·Î, Åë·Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin-ether sedimentation
    Æ÷¸£¸»¸°¿¡Å׸£Ä§Àü¹ý
  • phosphate-buffered saline
    Àλ꿰¿ÏÃæ½Ä¿°¼ö
  • association path
    ¿¬ÇÕµµ
  • path analysis
    °æ·ÎºÐ¼®
  • condyle path
    °üÀýÀ¶±â·Î
  • neutral fat
    Áß¼ºÁö¹æ
  • neutral hermaphroditism
    Áß¼º³²³àÇѸöÁõ
  • incisor path
    ¾Õ´Ï±æ, ÀýÄ¡·Î
  • neutral occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • neutral reaction
    ÁßÈ­¹ÝÀÀ
  • neutral salt
    Áß¼º¿°
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • path
    °æ·Î, Åë·Î
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Final common path
    ÃÖÁ¾(õÌðû)°øÅë(Íì÷×)Åë·Î(÷×ÖØ)
  • artificial condyle path
    Àΰø °ú·Î(¡­Î¨ÖØ).
  • incisal path
    ÀýÄ¡·Î(ôîöÍÖØ).
  • incisor path recording apparatus
    Àý´Ü·Î¹¦»ç±â(ôîÓ®ÖØÙÚÞÐÐï).
  • inclination of condyle path
    °ú·Î°æ»çµµ(Î¨ÖØÌËÞØöô).
  • inclination of lateral condyle path
    Ãø¹æ°ú·Î°æ»ç(µµ)(ö°Û°Î¨ÖØÌËÞØöô).
  • inclination of sagittal incisal path
    ½Ã»óÀýÄ¡·Î°¢(ãÅßÒôîöÍÖØÊÇ).
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î(¡­ÌèÖØ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • buffered charcoal yeast extract agar
    ź(÷©)È¿¸ðÃßÃâ ¿ÏÃæÇÑõ
  • saline, phosphate-buffered (PBS)
    Àλ꿰¿ÏÃæ½Ä¿°¼ö, PBS
  • formalin cresol
    Æ÷¸£¸»¸°Å©·¹Á¹.
  • formalin-zinc sulfate flotation procedure
    Æ÷¸£¸»¸°È²»ê¾Æ¿¬ºÎ¾ç¹æ¹ý
  • merthiolate iodine formalin
    ¸ÞƼ¿À·¹ÀÌÆ®¿äµåÆ÷¸£¸»¸°
  • sodium acetate formalin
    ¾Æ¼¼Æ®»ê³ªÆ®·ý Æ÷¸£¸»¸°
  • artificial condyle path
    Àΰø °ú·Î(¡­Î¨ÖØ).
  • association path
    ¿¬ÇÕµµ.
  • average path
    Æò±ÕµµÁ¤(¡­Ô³ïï).
  • band path
    ´ëµµ(ÓáÔ³)
  • efferent path
    ¿ø½É°æ·Î(êÀãýÌèÖØ).
  • end path
    Á¾·Î(ðûÖØ).
  • incisal path
    ÀýÄ¡·Î(ôîöÍÖØ).
  • incisor path recording apparatus
    Àý´Ü·Î¹¦»ç±â(ôîÓ®ÖØÙÚÞÐÐï).
  • inclination of condyle path
    °ú·Î°æ»çµµ(Î¨ÖØÌËÞØöô).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin-ether sedimentation technique
    Æ÷¸£¸»¸°¿¡Å׸£Ä§Àü¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin
    Æ÷¸£¸»¸°
  • light path
    ±¤·Î(ÎÃÖØ)
  • mean free path
    Æò±ÕÀÚÀ¯°æ·Î(øÁгí»ë¦ÌèÖØ)
  • optical path
    ±¤Çà·Î(ÎÃú¼ÖØ)
  • calcium-activated neutral proteinase
    Ä®½·ºÎȰ(Ý·üÀ) Áß¼º(ñéàõ)ÇÁ·ÎƼ³×À̽º
  • coupled neutral pump
    °ø¿ª(Íëæµ) ÁßÈ­(ñéûú) ÆßÇÁ
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • neutral fat
    Áß¼ºÁö¹æ(ñéàõò·Û¸)
  • neutral glycolipids
    Áß¼º´çÁöÁú(ñéàõÓØò·òõ)
  • neutral lipid
    Áß¼ºÁöÁú(ñéàõò·òõ)
  • neutral mutation
    Á߸³º¯ÀÌ(ñ騡܍ì¶)
  • neutral sugar
    Áß¼º ´ç(ñéàõÓØ)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin
    Æ÷¸£¸»¸°
  • neutral
    Áß¼ºÀÇ, ÁßÈ­ÀÇ
  • path
    °æ·Î, Åë·Î, ÆÐ½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FAB fast atom bombardment; formalin ammonium bromide; fragment, antigen-binding [of immunoglobulins]; Fr...
misc miscarriage; miscellaneous
BSS Bachelor of Sanitary Science; balanced salt solution; Bernard-Soulier syndrome; black silk suture; b...
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FFPE Formalin-fixed, paraffin-embedded
MPP Medial perforant path
PP Perforant Path
LPP lateral perforant path
BPW Buffered Peptone Water
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • formalin cresol
    Æ÷¸£¸»¸° Å©·¹Á¹
  • phosphate buffered saline
    Àλ꿰 ½Ä¿°¼ö
  • neutral
    Áß¼ºÀÇ, Á߸³ÀÇ, ÁßÈ­ÀÇ
    È­ÇÐÀûÀ¸·Î »ê¼ºµµ ¾Æ´Ï°í ¿°±â¼ºµµ ¾Æ´Ñ.
  • neutral formaldehyde
    Áß¼º Æ÷¸§ ¾Ëµ¥ÇÏÀ̵å
  • neutral occlusion
    Á¤»ó ±³ÇÕ
    µ¿ÀǾî=normal occlusion.
  • neutral space
    Á߸³°­, Á߸³ °ø°£
  • serum neutral fat
    Ç÷û Áß¼º Áö¹æ
    Ç÷û Áß¼º Áö¹æÀº ´ëºÎºÐÀÌ Æ®¸®±Û¸®¼¼¶óÀ̵åÀ̰í, ±× ³óµµ´Â À½½Ä¹°ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù.
  • artificial condyle path
    Àΰø °ú·Î
  • condylar path element
    °ú·ÎºÎ
  • efferent path
    ¿ø½É °æ·Î
  • end path
    Á¾·Î
  • functionally generated path
    ±â´É ¿îµ¿·Î
  • incisor path recording apparatus
    Àý´Ü·Î ¹¦»ç±â
    Gysi´Â ÇÏ¾Ç ¿îµ¿À» ±âÇÏÇÐÀûÀ¸·Î ¿¬±¸Çϱâ À§ÇÏ¿© ÇÏ¾Ç ÀüÄ¡ºÎÀÇ ¿îµ¿ ±ËÀûÀ» ±³ÇÕÆò¸é ¹× Á¤Á߸鿡 À־ ±â·ÏÇÏ´Â ÀåÄ¡¸¦ °í¾ÈÇß´Ù. ¹¦»ç±â´Â ÇÏ¾Ç ±³ÇÕÁ¦ Àü¸é¿¡ ÀåÄ¡µÈ´Ù. ¹¦±âħÀÇ Çϳª´Â ±³ÇÕ Æò¸é¿¡ À־ÀÇ ÀüÄ¡ºÎ Ãø¹æ ¿îµ¿ÀÇ ±ËÀûÀ» ±â·ÏÇϱâ À§ÇÏ¿© »ó¹æ ±³ÇÕÁ¦¿¡ ÇÏÇâÀ¸·Î, ´Ù¸¥ Çϳª´Â Á¤Áß¸é »óÀÇ °³Æó ¿îµ¿ ±ËÀûÀÌ ±â·ÏµÇ°Ô²û ¿·À¸·Î ÇâÇÏ¿© ÀåÄ¡µÇ¾î ÀÖ´Ù.
  • inclination of sagittal incisal path
    ½Ã»ó ÀýÄ¡·Î °¢
    1. ÇϾÇÀÇ ÀüÁø ¿îµ¿¿¡ À־, ÇÏ¾Ç ÀüÄ¡Á¡Àº ÀüÇϹæÀ¸·Î À̵¿Çؼ­ ½Ã»ó ÀüÄ¡·Î °¢À» ±×¸®´Âµ¥ ±× Á¦ 1»óÀÌ ±³ÇÕ Æò¸é°ú ÀÌ·ç´Â °¢À» ½Ã»ó ÀüÄ¡·Î °¢À̶ó°í ÇÑ´Ù. Gysi¿¡ ÀÇÇϸé 40?~80?, Nakasawa¿¡ ÀÇÇϸé 0?~62?, Æò±Õ 34?ÀÌ´Ù. ¹«Ä¡¾Ç¿¡¼­´Â °íÀ¯ÀÇ ¼öÄ¡°¡ ¾øÀ¸³ª, ±¸Ä¡ºÎ ±³µÎ°æ»ç¿Í Á¤ºñ·ÊÀûÀ¸·Î °ü°èµÇ¾î, ÀÇÄ¡ÀÇ ±â´É°ú °ü°è°¡ ±íÀ¸¹Ç·Î µµÄ¡ ¹è¿­ ½Ã¿¡ Àû´çÈ÷ Á¶Àý, ¼³Á¤ÇÑ´Ù. Æò±Õ½Ä±³±³±â¿¡¼­´Â 10?ÀÇ °ÍÀÌ ¸¹´Ù. 2. ÇϾÇÀÇ Ãø¹æ ¿îµ¿ ½Ã¿¡ ÀüÄ¡Á¡Àº Á¿ìÃøÀÇ Àü¿ÜÇϹæÀ¸·Î À̵¿ÇÏ¿© ¼ÒÀ§ °íµñ¾ÆÄ¡¸¦ ±×¸°´Ù. ÀÌ¿¡ ÀÇÇÏ¿© ¾ò¾îÁø °¢ÀÇ ±³ÇÕ Æò¸é¿¡ Åõ¿µÇÑ °¢À» Ãø¹æ ÀýÄ¡·Î °æ»çµµ¶ó°í Çϸç, Gysi¿¡ ÀÇÇÏ¿© Æò±Õ 120?¶ó°í ÇÑ´Ù. ±¸Ä¡ºÎÀÇ ±³µÎ °æ»ç¿Í ¿ªºñ·ÊÀûÀÎ °ü°è¸¦ ³ªÅ¸³½´Ù.
  • milled-in path
    ±â·Ï·Î, ¸¶¸ð ±³ÇÕ·Î, ÀÚµ¿ ¸¶¸ð ±³ÇÕ ¸¸°î
    ÇϾǰñÀÌ ¿îµ¿À» ÇÒ ¶§, »ó´ëµÇ´Â ±³ÇÕ ¸é¿¡´Â Ä¡¾Æ³ª ¾î¶² ÀåÄ¡°¡ µÇ¾î ÀÖ¾î À̰ÍÀÌ ±³ÇÕÁ¦ÀÇ ±³ÇÕ ¸é¿¡ ÀÚµ¿ÀûÀ¸·Î Á¶°¢µÇ¾î ³ªÅ¸³­ »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
neutral buffered formalin fixative A general histologic fixative less likely to leave formalin deposits in tissue than formol-saline fixative.
(05 Mar 2000)
buffered <pharmacology> Refers to pills coated with a special substance that neutralises stomach acid. Drugs are buffered to reduce stomach upset or increase absorption by the intestines.
(09 Oct 1997)
buffered crystalline penicillin G Crystalline potassium penicillin G or crystalline sodium penicillin G buffered with not less than 4% and not more than 5% of sodium citrate.
(05 Mar 2000)
formalin A 37% aqueous solution of formaldehyde.
Synonym: formol.
(05 Mar 2000)
formalin pigment <chemistry> A pigment formed when acid aqueous solutions of formaldehyde act on blood-rich tissues; characterised by rotation of the plane of polarised light, withstanding extraction in aqueous and lipid solvents, being bleached in acids and hydrogen peroxide; not formed when tissue is fixed with formaldehyde buffered to pH levels above 6.
(05 Mar 2000)
generated occlusal path A registration of the path's of movement of the occlusal surfaces of mandibular teeth on a plastic or abrasive surface attached to the maxillary arch.
See: functional chew-in record.
(05 Mar 2000)
mean free path <radiobiology> Average distance a particle travels between occurrences of the given event, for example, between collisions. For collisions, the mean free path is roughly equal to unity divided by the product of the collision cross-section times the particle density.
(09 Oct 1997)
path A road or way; the course taken by an electric current or by nervous impulses.
See: pathway.
Origin: A.S. Paeth
(05 Mar 2000)
path analysis A mode of analysis involving assumptions about the direction of causal relationships among linked sequences and configurations of variables.
(05 Mar 2000)
path function <chemistry> A property that is dependent on the path taken.
(09 Jan 1998)
path of insertion The direction in which a dental prosthesis is placed upon or removed from the supporting tissues or abutment teeth.
(05 Mar 2000)
condyle path The path traveled by the mandibular condyle in the temporomandibular joint during the various mandibular movements.
(05 Mar 2000)
incisal path The influence on mandibular movements caused by the contacting surfaces of the mandibular and maxillary anterior teeth during eccentric excursions.
Synonym: incisal path.
(05 Mar 2000)
occlusal path A gliding occlusal contact, the path of movement of an occlusal surface.
(05 Mar 2000)
Armillaria mellea neutral proteinase <enzyme> Specific for lysine
Registry number: EC 3.4.99.32
(26 Jun 1999)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
  • Path Buffered Neutral Formalin Misc - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Formalin
    Æ÷¸£¸»¸°
  • neutral
    Á߸³ÀÇ
  • Idiom Neutral
    À̵ð¾ö ´ºÆ®·²(1902³â¿¡ ¹ßÇ¥µÈ ÀΰøÀû ±¹Á¦ º¸Á¶¾î)
  • neutral
    Á߸³(±¹)ÀÇ;Á߸³±¹;ºÒÆíºÎ´çÀÇ;¾î´ÀÆíµµ µéÁö ¾Ê´Â;(Á¾·ù,Ư¡)ºÐ¸íÄ¡ ¾ÊÀº;(»öÀÌ)¹Ù·£;ȸ»öÀÇ;Áß¼ºÀÇ;¾Ï¼ö ±¸º°ÀÌ ¾ø´Â;(ÇôÀÇ À§Ä¡°¡)Áß¼ºÀÇ;Áß°£ÀÇ;Á߸®±¹(¹Î);Á߸³ÀÚ;(Àüµ¿±â¾îÀÇ)Á߸³(À§Ä¡)
  • neutral corner
    ´ºÆ®·² ÄÚ³Ê(°æ±âÀÚÀÇ ÈÞ°Ô¿ëÀ¸·Î ÁöÁ¤µÇ¾î ÀÖÁö ¾ÊÀº ÄÚ³Ê)
  • neutral current
    Á߸³Àû ¼Ò¸³ÀÚ·ù;Áß¼º Ä¿·»Æ®
  • neutral meson
    Áß¼º Áß°£ÀÚ(neutretto)
  • neutral mutation
    Á߸³µ¹¿¬º¯ÀÌ
  • neutral spirits
    Áß¼º ÁÖÁ¤(95µµ ÀÌ»ó¼ø¼ö ¾ËÄÚ¿Ã,º¸Åë ´Ù¸¥ ¼ú°ú ¼¯¾î¸¶½É)
  • neutral tint
    Áß°£»ö;¿¬ÇÑȸ»ö
  • neutral zone
    Áß°£Áö´ë
  • by-path
    ¿·±æ
  • path
    ÀÛÀº ±æ,º¸µµ
  • bridle path
    ½Â¸¶±æ
  • cinder path
    ¼®Åº À縦 ±ò¾Æ ´ÙÁø º¸µµ;=CINDER TRACK
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á